Huge appetite: An adult holding an infant in a store selling baby products in Shanghai. Despite the slide in shares of foreign firms, some analysts remain optimistic as many Chinese buyers opt for overseas brands because of their perceived quality. — Reuters
SHANGHAI: China’s shockingly low birthrate isn’t quite the calamity for overseas milk suppliers that some recent stock moves might suggest.
Foreign firms that make baby formula, from Swiss giant Nestle SA to France’s Danone SA, saw their shares fall after Beijing revealed last week that births in 2025 fell to the lowest since at least 1949.
The worst hit was New Zealand’s A2 Milk Co (A2 Milk), which plunged 14% immediately after the news as investors dumped a company known for its bullishness on China.
Chinese dairy companies, which are less keyed to the formula market, were relatively undisturbed.
Despite fewer Chinese babies, there’s evidence that firms with premium branding and international cachet can still grow their market share, and charge more for their products.
Even after A2 Milk’s shellacking last Monday, analysts seemed optimistic on the company’s future, with a majority recommending a “buy” or “hold” on the stock in the wake of the decline.
The New Zealand company has made no bones about its reliance on China. Its stock skyrocketed twice in 2025 after announcements that revealed greater penetration or spending in the Chinese market.
The purchase of a Chinese infant formula plant in August kicked off a rally that took its shares to their highest since 2021.
A2 Milk’s market value remains higher than before its Chinese investment.
Chinese milk production, meanwhile, may be peaking, according to the US Department of Agriculture, while many local buyers remain wedded to established overseas brands because of their perceived quality.
China’s huge appetite for imports developed apace after the melamine scandal in 2008, when tainted domestic formula sickened thousands of children.
So, while China’s birthrate has roughly halved over the past decade, formula imports from New Zealand, the No. 2 supplier after the Netherlands, have ballooned, according to Chinese customs data.
From 12 million kg in 2015, they peaked at 72 million kg in 2020 before dropping during the pandemic. They’ve crept higher since, to 64 million kg in 2025.
A2 Milk declined to comment during the blackout period ahead of its half-yearly results next month. In November, chief executive officer David Bortolussi listed capturing the full potential of China’s infant milk market as one of his five strategic priorities.
Falling birthrates, a phenomenon across richer countries, are obviously a drag on firms that make products for children. But parents generally are willing to pay up for the health and nutrition of their kids, offering growth prospects even as fertility declines.
International brands, meanwhile, often hold a strong appeal for China’s huge middle class.
According to NielsenIQ research last year, premium brands made up more than three-quarters of China’s infant formula market, compared to just over 20% for baby cereal and diapers.
Moreover, the super-premium category of formula grew while other segments flattened or fell.
Of the country’s top five infant formulas, three are supplied by foreign companies: the Friso brand from privately held Dutch firm Koninklijke FrieslandCampina NV, Danone’s Aptamil, and A2 Milk, according to data from Kantar Worldpanel, which tracks consumer choices.
It means that, at the very least, birthrates and formula sales aren’t necessarily correlated, and that avenues for growth remain open for companies that lean towards the more expensive end of the market.
“Consumers in China are willing to pay up for the A2 Milk brand,” Morningstar equity analyst Angus Hewitt said in a note last week. “This pricing power has driven market share growth despite unfavourable demographic conditions.” — Bloomberg
